NACL Industries Limited (NACLIND) - Total Assets
Based on the latest financial reports, NACL Industries Limited (NACLIND) holds total assets worth Rs13.64 Billion INR (≈ $147.50 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore NACL Industries Limited (NACLIND) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
NACL Industries Limited - Total Assets Trend (2006–2026)
This chart illustrates how NACL Industries Limited's total assets have evolved over time, based on quarterly financial data. See NACLIND net asset value for net asset value and shareholders' equity analysis.
NACL Industries Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
NACL Industries Limited's total assets of Rs13.64 Billion consist of 60.5% current assets and 39.6% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 2.5% |
| Accounts Receivable | Rs4.58 Billion | 33.6% |
| Inventory | Rs2.83 Billion | 20.7% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs0.00 | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2006–2026)
This chart illustrates how NACL Industries Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NACLIND stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NACL Industries Limited's current assets represent 60.5% of total assets in 2026, a decrease from 68.6% in 2006.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2026, down from 11.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 33.6% of total assets.
NACL Industries Limited Competitors by Total Assets
Key competitors of NACL Industries Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥58.40 Billion |
|
Hunan Haili Chemical Co Ltd
SHG:600731
|
China | CN¥4.46 Billion |
|
Jiangsu Lanfeng Bio-chemical Co Ltd
SHE:002513
|
China | CN¥4.06 Billion |
|
Insumos Agroquimicos SA
BA:INAG
|
Argentina | AR$45.35 Billion |
|
Nufarm Ltd
AU:NUF
|
Australia | AU$4.80 Billion |
|
Minbos Resources Ltd
AU:MNB
|
Australia | AU$36.78 Million |
|
Terragen Holdings Ltd
AU:TGH
|
Australia | AU$5.84 Million |
|
RLF Agtech Ltd
AU:RLF
|
Australia | AU$24.62 Million |
NACL Industries Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.27 | 0.97 | 1.53 |
| Quick Ratio | 0.84 | 0.60 | 1.02 |
| Cash Ratio | 0.00 | 0.08 | 0.00 |
| Working Capital | Rs1.77 Billion | Rs-213.00 Million | Rs2.39 Billion |
NACL Industries Limited - Advanced Valuation Insights
This section examines the relationship between NACL Industries Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.36 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 8.0% |
| Total Assets | Rs13.64 Billion |
| Market Capitalization | $452.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values NACL Industries Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: NACL Industries Limited's assets grew by 8.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for NACL Industries Limited (2006–2026)
The table below shows the annual total assets of NACL Industries Limited from 2006 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs13.64 Billion ≈ $147.50 Million |
+7.98% |
| 2025-03-31 | Rs12.63 Billion ≈ $136.60 Million |
-30.53% |
| 2024-03-31 | Rs18.18 Billion ≈ $196.64 Million |
-5.06% |
| 2023-03-31 | Rs19.15 Billion ≈ $207.13 Million |
+26.80% |
| 2022-03-31 | Rs15.10 Billion ≈ $163.35 Million |
+54.83% |
| 2021-03-31 | Rs9.76 Billion ≈ $105.51 Million |
+2.21% |
| 2020-03-31 | Rs9.55 Billion ≈ $103.23 Million |
+28.56% |
| 2019-03-31 | Rs7.42 Billion ≈ $80.30 Million |
+4.13% |
| 2018-03-31 | Rs7.13 Billion ≈ $77.11 Million |
+7.77% |
| 2017-03-31 | Rs6.62 Billion ≈ $71.55 Million |
+8.23% |
| 2016-03-31 | Rs6.11 Billion ≈ $66.10 Million |
-8.12% |
| 2015-03-31 | Rs6.65 Billion ≈ $71.94 Million |
+7.17% |
| 2014-03-31 | Rs6.21 Billion ≈ $67.13 Million |
+3.06% |
| 2013-03-31 | Rs6.02 Billion ≈ $65.14 Million |
-4.52% |
| 2012-03-31 | Rs6.31 Billion ≈ $68.22 Million |
+14.35% |
| 2011-03-31 | Rs5.52 Billion ≈ $59.66 Million |
-0.59% |
| 2010-03-31 | Rs5.55 Billion ≈ $60.01 Million |
+43.51% |
| 2009-03-31 | Rs3.87 Billion ≈ $41.82 Million |
+20.07% |
| 2008-03-31 | Rs3.22 Billion ≈ $34.83 Million |
+4.69% |
| 2007-03-31 | Rs3.08 Billion ≈ $33.27 Million |
+2.97% |
| 2006-03-31 | Rs2.99 Billion ≈ $32.31 Million |
-- |
About NACL Industries Limited
NACL Industries Limited manufactures and sells agrochemicals in India. The company offers a range of technical products, including myclobutanil, propiconazole, profenofos, tricyclazole, pretilachlors, thiamethoxam, lambda cyhalothrin, bifenthrin, azoxystrobin, tebuconazole, difenoconazole, thifluzamide, bispyribac sodium, clodinafop propargyl, metribuzin, quizalofop ethyl, haloxyfop r methyl, and… Read more